QIAGEN Digital Insights: Webinars and Events

English

Products

QCI Interpret for Oncology

The most advanced end-to-end solution for oncology NGS analysis, interpretation and reporting

Ingenuity Pathway Analysis (IPA)

Analyze, compare and contextualize your NGS data with the leading pathway analysis application

Knowledge Bases

Biomedical Knowledge Bases

Gene Variant Databases

COSMIC (Catalogue of Somatic Mutations in Cancer)

HSMD (Human Somatic Mutation Database)

HGMD (Human Gene Mutation Database)

PGXI (Pharmacogenomic Insights)

'Omics Databases

QIAGEN DiseaseLand

QIAGEN OncoLand

QIAGEN Single Cell Land

ATCC Cell Line Land

QIAGEN OmicSoft Land Explorer

Biomedical Knowledge Base-AI

Find novel connections missed by traditional methods, hiding in over 640M biomedical relationships

Discovery Bioinformatics Services

Clinical Analysis and Interpretation Services

QCI Precision Insights

Biomedical Knowledge Bases

Access critical drug discovery data, save time and explore novel biomedical relationships

QCI Precision Insights

A professional clinical interpretation service that translates molecular data specific to each patient into insights and therapeutic options

Biomedical Knowledge Base-HD

Directly access over 10M high-quality biological findings

QIAGEN receives European IVDR certification for QIAGEN Clincal Insight Interpret

Powerful cloud-enabled ‘omics GUI, complete NGS analysis workflows and unparalleled curated content for immediate exploration

Which secondary analysis solution is right for you?

Use our decision tree to find out which secondary analysis solution is right for your lab

Solutions

Discovery and Research

Biomarker Identification

Target Discovery

Mechanism of Action

Single-Cell Genomics

Microbial/Metagenomics

Gene Regulation

Variant Analysis

SARS-CoV-2 Solutions

OmicSoft NGS Data Analysis

Explore and compare data across 700K+ disease studies with a cloud-based NGS analysis suite

Data and Pipeline Management

OmicSoft OncoLand

Explore high-quality, preprocessed genomics data with our oncology database

Webinar: How decentralized and small labs can adopt high-throughput NGS analysis

Discover a new secondary analysis solution for oncology & inherited disease applications for high-throughput use with any clincal NGS data

Clinical NGS Testing

Hematological Malignancies

Hereditary Cancers

Inherited Disorders

Rare & Undiagnosed Diseases

Carrier Screening

Cardiac Discorders

Cardiomyopathies

Sample to Insight solutions

View our NGS workflows for labs of all sizes and experience - and find the right fit for you

Partner Program

Biomarker and Target Discovery

Augment your biomarker discovery research with 20M findings & 700K preprocessed ` omics samples

Rare and Undiagnosed Diseases

Finding a diagnosis for rare diseases is often a race against time. QDI is helping provide answers where none were available before

Clinical Testing Solutions

Deliver partient-specific reports for any NGS panel in minutes with on-demand, expert-curated content & professional interpretation services

Resources

Webinars and Events

Upcoming Webinars

Webinar Recordings

App Notes & White Papers

Public Citations

Citation Guidelines

Allele Frequency Community

SARS-CoV-2 Resources

Knowledge Bases Blog: Using trusted cancer data can accelerate drug discovery and development

See our expert curation processes and how data curated this way helps biopharma research

Latest IPA Blog: Free pathway analysis - How much do you really save?

Discover why you need pathway analysis tools that provide rich, directional relationships

Latest Blog: Immune Repertoire Analysis Showdown: Speed, Ease, Accuracy

Find out which B-cell receptor reconstruction tool takes the crown

Webinar: Investigating genomic variants with QDI Software

Learn to analyze various types of NGS data with CLC Genomics Workbench, QCII Translational and IPA

Blog: How COSMIC & HSMD support different phases of cancer drug discovery and development

Learn how expert-curated cancer data can help biopharma researchers identify & validate drug targets faster & optimize clinical trial design

Support

Technical Support

Contact Support

Product Manuals

Maintenance and Support

VIdeo: Introduction to QCI Interpret for Oncology

Check out this introductory video to QCI Interpret for Oncology, a CDS software that will allow you to confidently interpret NGS variants

Lateset improvements: IPA

See the newest improvements and updates in the IPA 2024R1 Release

Omicsoft Training

QIAGEN CLC Tutorials

Webinar: Leveraging the QIAGEN Knowledge Graph for insights into drug repurposing

This webinar shows how to predict novel drug-disease relationships and construct networks that capture relevant supporting evidence

Webinar: HGMD Pro in action: Search, curate and classify genetic variants - Session 2

Learn how HGMD Professional can help you get better variant data faster

Product Downloads

Module and Plugin Downloads

Somatic knowledge bases for clinical NGS testing

Expert-curated content for accelerated analysis of cancer mutations in clincal NGS testing

System requirements

License transfer

Somatic knowledge bases for biopharmaceutical research

Expert-curated content for the discovery and development of precision cancer therapies

Human Gene Mutation Database (HGMD) Professional

Improve diagnostics with the largest expert-curated source of hereditary disease-causing mutations

Latest improvements: OmicsSoft Lands

See the latest improvements and updates in the Lands 2024R1 Release

Video: Introduction to QCI for Hereditary Disorders

Check out this introductory video to QCI Interpret for Hereditary Disorders, industry's only automated FASTQ to final report solution

Press Release: QIAGEN enchances bioinformatics workflows with new secondary analysis solultion

QIAGEN launches QCI Secondary Analysis, a cloud-based solution enabling high-throughput secondary analysis with clincal NGS data

About

Careers | QIAGEN Digital Insights

QIAGEN Corporate

Request a Trial

How to purchase

Home > biomarker research

Cross-species comparison and validation for drug discovery and biomarker research using QIAGEN Ingenuity Pathway Analysis (IPA)

Cross-species comparison and validation for drug discovery and biomarker research using QIAGEN Ingenuity Pathway Analysis (IPA)

Monday, August 14, 2023

Some human studies may be unfeasible or unethical, making cross-species research critical for drug discovery and biomarker validation. Cross-species research...

Read more

Sample to Insight

© QIAGEN 2013–24. All rights reserved

Privacy Policy Sitemap Trademarks & Disclaimers Terms & Conditions

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.